* Ranbaxy Labs to pay up to $500-m fine in settlement with US FDA, forecast cut * Govt bond rating outlook stable, confirms Moody’s * Finmin proposes retrospective 2G spectrum pricing * Coal imports may touch $30 bn/yr, rival bill for crude * Pension reforms now a casualty as Mamata plays spoilsport again